BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30547469)

  • 1. Evaluation of Pulmonary Toxicity of Nanoparticles by Bronchoalveolar Lavage.
    Mo Y; Zhang Y; Zhang Q
    Methods Mol Biol; 2019; 1894():313-322. PubMed ID: 30547469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration.
    Van Hoecke L; Job ER; Saelens X; Roose K
    J Vis Exp; 2017 May; (123):. PubMed ID: 28518083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technical considerations and precautions in in situ bronchoalveolar lavage and alveolar infiltrating cells isolation in rats.
    Qamar W
    Toxicol Mech Methods; 2015; 25(7):547-51. PubMed ID: 26099601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative mouse lung injury by nickel nanoparticles with differential surface modification.
    Mo Y; Jiang M; Zhang Y; Wan R; Li J; Zhong CJ; Li H; Tang S; Zhang Q
    J Nanobiotechnology; 2019 Jan; 17(1):2. PubMed ID: 30616599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Bronchoalveolar Lavage to Evaluate Changes in Pulmonary Diseases.
    Di ME; Yang D; Di YP
    Methods Mol Biol; 2020; 2102():117-128. PubMed ID: 31989551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a syringe aspiration technique versus a mechanical suction technique and use of N-butylscopolammonium bromide on the quantity and quality of bronchoalveolar lavage fluid samples obtained from horses with the summer pasture endophenotype of equine asthma.
    Bowser JE; Costa LRR; Rodil AU; Lopp CT; Johnson ME; Wills RW; Swiderski CE
    Am J Vet Res; 2018 Mar; 79(3):348-355. PubMed ID: 29466051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simplified method for bronchoalveolar lavage in mice by orotracheal intubation avoiding tracheotomy.
    Luckow B; Lehmann MH
    Biotechniques; 2021 Oct; 71(4):534-537. PubMed ID: 34517774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary toxicity screening studies in male rats with M5 respirable fibers and particulates.
    Warheit DB; Webb TR; Reed KL
    Inhal Toxicol; 2007 Sep; 19(11):951-63. PubMed ID: 17849279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histamine bronchoprovocation does not affect bronchoalveolar lavage fluid cytology, gene expression and protein concentrations of IL-4, IL-8 and IFN-gamma.
    Perkins GA; Viel L; Wagner B; Hoffman A; Erb HN; Ainsworth DM
    Vet Immunol Immunopathol; 2008 Dec; 126(3-4):230-5. PubMed ID: 18829118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung toxicity assessment using bronchoalveolar lavage fluid and pleural lavage fluid cytology by intratracheal treatment in rats.
    Takehara H; Makita M; Tanaka R; Tsuchiya M; Naya M; Hayashi M
    J Toxicol Sci; 2014 Feb; 39(1):141-5. PubMed ID: 24418718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute pulmonary effects of combined exposure to carbon nanotubes and ozone in mice.
    Han SG; Andrews R; Gairola CG; Bhalla DK
    Inhal Toxicol; 2008 Feb; 20(4):391-8. PubMed ID: 18302047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of antisense oligonucleotide to nuclear factor-kappaB on the development of bleomycin-induced pulmonary fibrosis and IL-4 expression therein: experiment with mice].
    Zhang XY; Zhou Y; Liu WQ; Zhao L; Li SQ
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):195-9. PubMed ID: 17425852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of bronchoscopic and nonbronchoscopic bronchoalveolar lavage in healthy cats.
    Hooi KS; Defarges AM; Sanchez AL; Nykamp SG; Weese JS; Abrams-Ogg ACG; Bienzle D
    Am J Vet Res; 2018 Nov; 79(11):1209-1216. PubMed ID: 30372158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles.
    Sayes CM; Reed KL; Warheit DB
    Toxicol Sci; 2007 May; 97(1):163-80. PubMed ID: 17301066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
    Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
    Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive severe lung injury by zinc oxide nanoparticles; the role of Zn2+ dissolution inside lysosomes.
    Cho WS; Duffin R; Howie SE; Scotton CJ; Wallace WA; Macnee W; Bradley M; Megson IL; Donaldson K
    Part Fibre Toxicol; 2011 Sep; 8():27. PubMed ID: 21896169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of bronchoalveolar lavage to detect respiratory tract toxicity of inhaled material.
    Henderson RF
    Exp Toxicol Pathol; 2005 Jul; 57 Suppl 1():155-9. PubMed ID: 16092723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidized BAL fluid proteins in patients with interstitial lung diseases.
    Lenz AG; Costabel U; Maier KL
    Eur Respir J; 1996 Feb; 9(2):307-12. PubMed ID: 8777969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats.
    Warheit DB; Laurence BR; Reed KL; Roach DH; Reynolds GA; Webb TR
    Toxicol Sci; 2004 Jan; 77(1):117-25. PubMed ID: 14514968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchoalveolar lavage: sampling technique and guidelines for cytologic preparation and interpretation.
    Hoffman AM
    Vet Clin North Am Equine Pract; 2008 Aug; 24(2):423-35, vii-viii. PubMed ID: 18652963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.